PROGNOSTIC ROLE OF MOLECULAR SUBTYPES OF COLON CANCER. A CURRENT VIEW ON THE PROBLEM

PROGNOSTIC ROLE OF MOLECULAR SUBTYPES OF COLON CANCER. A CURRENT VIEW ON THE PROBLEM

Purpose of the study: to review the available data on the heterogeneity of colon cancer and to assess the prognostic significance of colon cancer subtypes.Material and Methods. Medline, PubMed, Cochrane library, elibrary databases were used to identify studies that characterized the current view on...

Full description

Bibliographic Details
Main Authors:	L. E. Sinyansky, S. V. Vtorushin, S. V. Patalyak, S. G. Afanasyev
Format:	Article
Language:	Russian
Published:	Tomsk National Research Medical Center of the Russian Academy of Sciences 2021-06-01
Series:	Sibirskij Onkologičeskij Žurnal
Subjects:	colon cancer molecular subtypes adjuvant chemotherapy prognostic factors
Online Access:	https://www.siboncoj.ru/jour/article/view/1816

Similar Items

Perineural Invasion Is a Strong Prognostic Factor but Not a Predictive Factor of Response to Adjuvant Chemotherapy in Node-Negative Colon Cancer
by: Junhao Tu, et al.
Published: (2021-03-01)

Ki-67 as a prognostic marker according to breast cancer molecular subtype
by: Nahed A. Soliman, et al.
Published: (2016-12-01)

Identification and Validation of a Novel Six-Gene Prognostic Signature of Stem Cell Characteristic in Colon Cancer
by: Yichao Liang, et al.
Published: (2021-02-01)

Improving clinical management of colon cancer through CONNECTION, a nation-wide colon cancer registry and stratification effort (CONNECTION II trial): rationale and protocol of a single arm intervention study
by: I. van den Berg, et al.
Published: (2020-08-01)

Associations of P Score With Real-World Survival Improvement Offered by Adjuvant Chemotherapy in Stage II Colon Cancer: A Large Population-Based Longitudinal Cohort Study
by: Qi Liu, et al.
Published: (2021-02-01)

Molecular subtypes based on CNVs related gene signatures identify candidate prognostic biomarkers in lung adenocarcinoma
by: Baihui Li, et al.
Published: (2021-07-01)

Adjuvant Chemotherapy for Stage III Colon Cancer
by: Julien Taieb, et al.
Published: (2020-09-01)

Investigation of colorectal cancer in accordance with consensus molecular subtype classification
by: Hiroshi Sawayama, et al.
Published: (2020-09-01)

Identification and validation of poor prognosis immunoevasive subtype of muscle-invasive bladder cancer with tumor-infiltrating podoplanin+ cell abundance
by: Quan Zhou, et al.
Published: (2020-01-01)

Evaluation of the adverse effect profile of the adjuvant treatment in patients with stage II-III colon cancer
by: Kerim Çayır, et al.
Published: (2010-06-01)

Molecular-Subtype-Specific Biomarkers Improve Prediction of Prognosis in Colorectal Cancer
by: Jesper Bertram Bramsen, et al.
Published: (2017-05-01)

Survival and time interval from surgery to the start of chemotherapy for patients with stage II and III colon cancer
by: Denis Ganenko, et al.
Published: (2019-01-01)

Choice of adjuvant drug therapy on the basis of the molecular classification of breast cancer
by: N. S. Besova
Published: (2014-07-01)

Prognostic factors of overall survival for patients with stage II colon cancer
by: Harsha Trivedi, et al.
Published: (2014-11-01)

Molecular Subtypes Based on the Stemness Index Predict Prognosis in Glioma Patients
by: Jun Tan, et al.
Published: (2021-03-01)

Identification of Distinct Molecular Patterns and a Four-Gene Signature in Colon Cancer Based on Invasion-Related Genes
by: Yunfei Dong, et al.
Published: (2021-08-01)

The outcomes and prognostic factors in patients with osteosarcoma according to age: a Japanese nationwide study with focusing on the age differences
by: Yusuke Tsuda, et al.
Published: (2018-05-01)

ADJUVANT CHEMOTHERAPY OF PRIMARY OPERABLE LUMINAL B BREAST CANCER WITHOUT OVEREXPRESSION OF HER2/NEU IN POSTMENOPAUSAL WOMEN: YES OR NO?
by: Yu. S. Shatova, et al.
Published: (2017-12-01)

Results of combination treatment using docetaxel in an adjuvant chemotherapy regimen for resectable breast cancer
by: L. V. Bolotina, et al.
Published: (2014-07-01)

Adjuvant chemotherapy in stage II–III operated colon cancer patients from a nontrial cohort in a low colon cancer prevalence country with predominant use of modified CAPOX
by: Anant Ramaswamy, et al.
Published: (2019-01-01)

Personalized Medicine—Current and Emerging Predictive and Prognostic Biomarkers in Colorectal Cancer
by: Christine Koulis, et al.
Published: (2020-03-01)

Prognostic & predictive factors for planning adjuvant chemotherapy of early-stage breast cancer
by: Onur Esbah, et al.
Published: (2017-01-01)

Identification and validation of an excellent prognosis subtype of muscle-invasive bladder cancer patients with intratumoral CXCR5+ CD8+ T cell abundance
by: Qiuren Huang, et al.
Published: (2020-01-01)

Molecular Classification Based on Prognostic and Cell Cycle-Associated Genes in Patients With Colon Cancer
by: Zhiyuan Zhang, et al.
Published: (2021-04-01)

Optimal schedule of adjuvant chemotherapy with S-1 for stage III colon cancer: study protocol for a randomized controlled trial
by: Yoshimura Kenichi, et al.
Published: (2013-01-01)

The effect of smoking, obesity and diabetes on recurrence‐free and overall survival in patients with stage III colon cancer receiving adjuvant chemotherapy
by: Alex Croese, et al.
Published: (2021-06-01)

Right- and left-sided stage III colon cancers present different prognostic outcomes of oxaliplatin-based adjuvant chemotherapy after curative resection
by: Peng J, et al.
Published: (2018-07-01)

Glutathione S-transferase Pi expression predicts response to adjuvant chemotherapy for stage C colon cancer: a matched historical control study
by: Jankova Lucy, et al.
Published: (2012-05-01)

Integration of NRP1, RGS5, and FOXM1 expression, and tumour necrosis, as a postoperative prognostic classifier based on molecular subtypes of clear cell renal cell carcinoma
by: Takashi Yoshida, et al.
Published: (2021-11-01)

Prognostic and Predictive Cross-Roads of Microsatellite Instability and Immune Response to Colon Cancer
by: Luigi Laghi, et al.
Published: (2020-12-01)

Microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients: results from a population‐based study
by: Elizabeth Alwers, et al.
Published: (2020-02-01)

Validation of a quantitative 12-multigene expression assay (Oncotype DX® Colon Cancer Assay) in Korean patients with stage II colon cancer: implication of ethnic differences contributing to differences in gene expression
by: Jeong DH, et al.
Published: (2015-12-01)

Wheatgrass Juice Administration and Immune Measures during Adjuvant Chemotherapy in Colon Cancer Patients: Preliminary Results
by: Adva Avisar, et al.
Published: (2020-06-01)

Factors associated with efficacy of FOLFIRI/aflibercept in patients with metastatic colon cancer
by: M. Yu. Fedyanin, et al.
Published: (2019-06-01)

Prognostic and predictive value of the macroscopic growth pattern in patients undergoing curative resection of colorectal cancer: a single-institution retrospective cohort study of 4,080 Chinese patients
by: Li X, et al.
Published: (2018-07-01)

Retrospective analysis of the impact of anthracycline dose reduction and chemotherapy delays on the outcomes of early breast cancer molecular subtypes
by: Sigita Liutkauskiene, et al.
Published: (2018-04-01)

Safety and efficacy of a modified XELOX adjuvant regimen for patients with operated stage III colon cancer: a Chinese single-center experience
by: Jianhong Peng, et al.
Published: (2019-10-01)

Is Radical Surgery Alone Enough in T1-3N1a Colon Cancer?
by: Guoxiong Xu, et al.
Published: (2020-10-01)

Identification of Clinical Relevant Molecular Subtypes of Pheochromocytoma
by: Umair Ali Khan Saddozai, et al.
Published: (2021-06-01)

Low tumor purity is associated with poor prognosis, heavy mutation burden, and intense immune phenotype in colon cancer
by: Mao Y, et al.
Published: (2018-09-01)